1. Academic Validation
  2. CircATP5SL promotes infantile haemangiomas progression via IGF1R regulation by targeting miR-873-5p

CircATP5SL promotes infantile haemangiomas progression via IGF1R regulation by targeting miR-873-5p

  • Am J Transl Res. 2021 Mar 15;13(3):1322-1336.
Zhiqiang Wei 1 Xiaoqi Yuan 1 Qi Ding 2 Yanan Xu 1 Lu Hong 3 Jianhua Wang 1 3
Affiliations

Affiliations

  • 1 The Department of Pediatric Surgery, The Ningbo Women and Children's Hospital Ningbo 315211, China.
  • 2 The Department of Diagnosis, Ningbo Diagnostic Pathology Center Ningbo 315021, China.
  • 3 The Department of Radiology, The Affiliated Hospital of Medical School of Ningbo University, Ningbo University School of Medicine Ningbo 315020, Zhejiang Province, China.
PMID: 33841659
Abstract

Infantile haemangiomas (IH) are the most common soft-tissue tumours in infants. Several studies have demonstrated the importance of circular RNA (circRNA) for the regulation of various Cancer cells. The present study aims to evaluate the functions and molecular mechanisms of circATP5SL in IH progression. In this study, we found that circATP5SL is significantly dysregulated in IH. We conducted Transwell, MTT, and flow cytometry analysis to evaluate the role of circATP5SL in IH cell proliferation, invasion, migration, and Apoptosis. Meanwhile, by using subcellular distribution detection, as well as dual-luciferase reporter test and RIP analysis, it has been confirmed that miR-873-5p directly binds to the 3'UTR of IGF1R mRNA, thereby inhibiting the expression of IGF1R. Besides, circATP5SL promoted IGF1R expression by directly adsorbing miR-873-5p, an IGF1R inhibitor, thereby promoting cellular invasion, proliferation, and migration as well as inhibition of Apoptosis. In summary, our study suggests that circATP5SL promotes IH progression by regulating IGF1R expression through adsorption of miR-873-5p, elucidating circATP5SL as a promising therapeutic target for the prognostication and treatment of IH.

Keywords

IGF1R; Infantile haemangiomas; circATP5SL; circRNA; miR-873-5p.

Figures
Products